Anzeige
Mehr »
Freitag, 19.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
71 Leser
Artikel bewerten:
(0)

Rebecca Love, Experienced Nurse Innovator and Entrepreneur, Joins the Nurse-1-1 Board of Directors

Board Addition Significantly Expands Digital Healthcare Expertise for Nurse-1-1

BOSTON, MA / ACCESSWIRE / April 28, 2022 / Nurse-1-1, the first conversational marketing company for healthcare, today announced that Rebecca Love, seasoned nurse executive, has joined the Nurse-1-1 Board of Directors. Love joins Michael Sheeley, CEO and co-founder, Nurse-1-1 and Joe Raczka, Chief Investment Officer, co-founder, and managing partner, York IE.

"We are extremely excited to welcome Rebecca to our board," said Sheeley. "At Nurse-1-1, our mission is to ensure that nurses are on the front lines as we transition to digital health. So nurses are at the heart of everything we do. Rebecca embodies the best of what it means to be a nurse and so we are thrilled to have her join our board to ensure we stay true to our mission."

Love is an experienced thought leader on nurse innovation and entrepreneurship. She is currently the Chief Clinical Officer at IntelyCare, an intelligent workforce management solution for healthcare facilities. Prior to IntelyCare, she held several senior nursing roles, including founding HireNurses.com, acquired by Ryalto in March 2018, where she then served as the Managing Director for US markets. She was also the Principal of Clinical Innovation for OptimizeRx Corporation, a platform offering a unique solution for patient adherence to medications by providing convenient access to financial assistance and critical clinical information.

"I'm thrilled to be joining the Nurse-1-1 Board of Directors," said Love. "Nurse-1-1 is leading the charge to change the status quo in healthcare - a cause I am incredibly passionate about. I see a future where Nurse-1-1 services as a core element to all patient touch points within digital healthcare."

Love designed and built the first nurse innovation program in the United States at Northeastern University, which led her to found the Society of Nurse Scientists, Innovators, Entrepreneurs & Leaders (SONSIEL), a 501C-3 non-profit where she serves as president. As a nurse leader, Love was the first nurse featured on Ted.com and on the inaugural nursing panel at SXSW. She has also co-authored two books, speaks internationally, and is dedicated and passionate about empowering nurses to be at the forefront of healthcare innovation and entrepreneurship.

This news follows the closing of Nurse-1-1's $2.3 million seed round to pioneer conversational marketing for healthcare, led by Argon Ventures with participation from York IE and Hyperplane. The funds will be used to further the Nurse-1-1 mission to build the first HIPAA-compliant platform for digital conversations between nurses and patients that can easily be embedded into other digital platforms.

Sheeley and Love will sit down on International Nurses Day, May 12, 2022, for a fireside chat to discuss the future of digital health and what the future holds for nurses. Topics will include how digital health platforms can improve access to care, ways to improve patient engagement, and the latest advancements in healthcare delivery. Click here to reserve your spot for this engaging conversation between two seasoned healthcare executives.

Interested in helping Nurse-1-1 achieve this mission? Visit nurse-1-1.com/careers to learn more.

About Nurse-1-1:

Nurse-1-1 is a conversational marketing company for healthcare that is bringing nurses to the front lines of digital health. Through a nationwide network of nurses and a HIPAA-compliant complete customer service platform, Nurse-1-1 offers a live nurse chat tool that can be embedded directly into other digital platforms, which helps patients make better decisions leading to increased adherence. At-home testing, pharmaceutical, and digital health companies of all sizes rely on Nurse-1-1 to improve education, increase adherence and increase patient satisfaction. Drive greater adherence at nurse-1-1.com.

Media Contacts:
Bailey Carroll
Nurse-1-1
bailey@nurse-1-1.com

Meaghan McGrath
York IE
meaghan@york.ie

SOURCE: Nurse-1-1



View source version on accesswire.com:
https://www.accesswire.com/699263/Rebecca-Love-Experienced-Nurse-Innovator-and-Entrepreneur-Joins-the-Nurse-1-1-Board-of-Directors

© 2022 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.